Free Stock Tips

Hi Everybody,

We had another roller coaster day of trading on Tuesday.

Tuesday’s alert presented traders with a couple profit opportunities with intraday moves of 50% and 20%.

Congratulations to traders who took advantage of these swings.

On to the next one.

For Wednesday we found a stock with a very exciting story that could become very active based on an awareness campaign.

Our alert for Wednesday is Nuvilex, Inc., NVLX
The stock closed Tuesday at 13 cents

NVLX is a biotechnology company, which develops and markets products to improve the health, condition, and well-being of people around the world.

NVLX offers Cinnechol, a natural supplement, which helps in maintaining normal cholesterol levels and supports normal cardiovascular function.

NVLX also offers Cinnergen, a liquid whole food nutritional supplement that provides nutrients to help the body process glucose; Cinnsational, a liquid nutritional supplement, which helps the body to combat symptoms associated with alcohol sensitivity, including nausea, fatigue, and headaches; and Citroxin, a surface cleaner for bacterial health threats, as well as an antiviral cleaner against swine flu virus and bird flu virus.

NVLX is developing cell therapy products and has completed its Phase 2 clinical trials. NVLX sells its products directly through its Websites, as well as through resellers and retail distributors.

NVLX has also benefited tremendously from a recent CNN program hosted by Dr Sanjay Gupta. Dr Gupta’s documentary, Weed, which aired on Sunday, August 11 at 8 p.m. ET on CNN, took a very hard look at the effects and benefits of the drug, for which Dr Gupta, CNN’s chief medical correspondent, apologized for his earlier stance against the drug, stating “… I apologize because I didn’t look hard enough, until now.”

A recent research report on NVLX says “investors may also be rewarded by upcoming milestones such as the pending closing of the diabetes technology treatment rights acquisition which was originally announced in 3Q13. This deal should immediately boost the Firm’s valuation, upon closing. Plus, investors can expect to receive progress reports regarding the Firm’s advanced clinical trials initiatives such as the production of the live cancer-drug-activating cells that will form part of the treatment to be used in its pancreatic cancer studies and the GMP facility in which the actual encapsulation of those cells will take place.”

We don’t necessarily care if any of this comes to fruition, but we do know that millions of investors learning about NVLX Wednesday morning will be pretty excited about the prospects.

That incoming liquidity will present some excellent trading opportunities on NVLX.

Make sure NVLX is on top of your watchlist Wednesday morning.

As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading